OSAM
PRAH

O'Shaughnessy Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,056
Closed -$174K – 2941
2021
Q2 		$174K Buy
1,056
+1,045
+9,500% +$174K ﹤0.01% 1094
2021
Q1 		$2K Buy
11
+8
+267% +$1.09K ﹤0.01% 2120
2020
Q4 		$0 Sell
3
-6
-67% -$671 ﹤0.01% 2299
2020
Q3 		$1K Buy
+9
New +$918 ﹤0.01% 1841
2019
Q1 		– Sell
-2,405
Closed -$222K – 1041
2018
Q4 		$222K Sell
2,405
-626
-21% -$63.3K 0.01% 480
2018
Q3 		$331K Sell
3,031
-9,554
-76% -$995K 0.01% 448
2018
Q2 		$1.17M Sell
12,585
-4,845
-28% -$417K 0.02% 234
2018
Q1 		$1.45M Sell
17,430
-420
-2% -$37.3K 0.03% 210
2017
Q4 		$1.63M Buy
17,850
+45
+0.3% +$3.74K 0.04% 218
2017
Q3 		$1.36M Buy
17,805
+7,063
+66% +$534K 0.03% 249
2017
Q2 		$806K Buy
+10,742
New +$745K 0.02% 305

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

O'Shaughnessy Asset Management's PRAH Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,056 shares — an estimated $174K sold.

O'Shaughnessy Asset Management first reported a position in PRAH in Q2 2017 and held it in 11 quarters. The position peaked at $1.63M in Q4 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,056 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $174K.
  • O'Shaughnessy Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 11 quarters.
  • O'Shaughnessy Asset Management's PRA Health Sciences, Inc. position peaked at $1.63M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.